Literature DB >> 26975929

Early Radiosurgery Improves Hearing Preservation in Vestibular Schwannoma Patients With Normal Hearing at the Time of Diagnosis.

Berkcan Akpinar1, Seyed H Mousavi2, Michael M McDowell3, Ajay Niranjan3, Amir H Faraji3, John C Flickinger4, L Dade Lunsford3.   

Abstract

PURPOSE: Vestibular schwannomas (VS) are increasingly diagnosed in patients with normal hearing because of advances in magnetic resonance imaging. We sought to evaluate whether stereotactic radiosurgery (SRS) performed earlier after diagnosis improved long-term hearing preservation in this population. METHODS AND MATERIALS: We queried our quality assessment registry and found the records of 1134 acoustic neuroma patients who underwent SRS during a 15-year period (1997-2011). We identified 88 patients who had VS but normal hearing with no subjective hearing loss at the time of diagnosis. All patients were Gardner-Robertson (GR) class I at the time of SRS. Fifty-seven patients underwent early (≤2 years from diagnosis) SRS and 31 patients underwent late (>2 years after diagnosis) SRS. At a median follow-up time of 75 months, we evaluated patient outcomes.
RESULTS: Tumor control rates (decreased or stable in size) were similar in the early (95%) and late (90%) treatment groups (P=.73). Patients in the early treatment group retained serviceable (GR class I/II) hearing and normal (GR class I) hearing longer than did patients in the late treatment group (serviceable hearing, P=.006; normal hearing, P<.0001, respectively). At 5 years after SRS, an estimated 88% of the early treatment group retained serviceable hearing and 77% retained normal hearing, compared with 55% with serviceable hearing and 33% with normal hearing in the late treatment group.
CONCLUSIONS: SRS within 2 years after diagnosis of VS in normal hearing patients resulted in improved retention of all hearing measures compared with later SRS.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26975929     DOI: 10.1016/j.ijrobp.2016.01.019

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

1.  Hearing Preservation in Stereotactic Radiosurgery for Vestibular Schwannoma.

Authors:  Anthony M Tolisano; Jacob B Hunter
Journal:  J Neurol Surg B Skull Base       Date:  2019-01-10

2.  Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.

Authors:  Kunal S Patel; Edwin Ng; Taranjit Kaur; Tyler Miao; Tania Kaprealian; Percy Lee; Nader Pouratian; Michael T Selch; Antonio A F De Salles; Quinton Gopen; Stephen Tenn; Isaac Yang
Journal:  J Neurooncol       Date:  2019-09-24       Impact factor: 4.130

3.  Long term results of primary radiosurgery for vestibular schwannomas.

Authors:  Stephen Johnson; Hideyuki Kano; Andrew Faramand; Matthew Pease; Aya Nakamura; Mohab Hassib; David Spencer; Nathaniel Sisterson; Amir H Faraji; Yoshio Arai; Edward Monaco; Ajay Niranjan; John C Flickinger; L Dade Lunsford
Journal:  J Neurooncol       Date:  2019-09-18       Impact factor: 4.130

Review 4.  The Management and Imaging of Vestibular Schwannomas.

Authors:  E P Lin; B T Crane
Journal:  AJNR Am J Neuroradiol       Date:  2017-05-25       Impact factor: 3.825

5.  EANO guideline on the diagnosis and treatment of vestibular schwannoma.

Authors:  Roland Goldbrunner; Michael Weller; Jean Regis; Morten Lund-Johansen; Pantelis Stavrinou; David Reuss; D Gareth Evans; Florence Lefranc; Kita Sallabanda; Andrea Falini; Patrick Axon; Olivier Sterkers; Laura Fariselli; Wolfgang Wick; Joerg-Christian Tonn
Journal:  Neuro Oncol       Date:  2020-01-11       Impact factor: 12.300

6.  Long-Term Hearing Outcomes Following Stereotactic Radiosurgery in Vestibular Schwannoma Patients-A Retrospective Cohort Study.

Authors:  Peter L Santa Maria; Yangyang Shi; Richard K Gurgel; C Eduardo Corrales; Scott G Soltys; Chloe Santa Maria; Kevin Murray; Steven D Chang; Nikolas H Blevins; Iris C Gibbs; Robert K Jackler
Journal:  Neurosurgery       Date:  2019-10-01       Impact factor: 4.654

7.  Stereotactic radiosurgery and fractionated stereotactic radiosurgery for vestibular schwannomas: A comparison of clinical outcomes from the RSSearch patient registry.

Authors:  Raj Singh; Hayden Ansinelli; Jan Jenkins; Joanne Davis; Sanjeev Sharma; John Austin Vargo
Journal:  J Radiosurg SBRT       Date:  2019

8.  Useful hearing preservation is improved in vestibular schwannoma patients who undergo stereotactic radiosurgery before further hearing deterioration ensues.

Authors:  Akiyoshi Ogino; Hao Long; Stephen Johnson; Andrew Faramand; Ajay Niranjan; John C Flickinger; L Dade Lunsford; Hideyuki Kano
Journal:  J Neurooncol       Date:  2021-03-17       Impact factor: 4.130

9.  Outcome of hearing preservation related to tumor morphologic analysis in acoustic neuromas treated by gamma knife radiosurgery.

Authors:  Szu-Yen Pan; Shih-An Liu; Ming-Hsi Sun; Hsi-Kai Tsou; Shinh-Dung Lee; Yen-Ju Chen; Jason Sheehan; Meei-Ling Sheu; Hung-Chuan Pan
Journal:  Radiat Oncol       Date:  2017-08-15       Impact factor: 3.481

10.  Outcome after Radiotherapy for Vestibular Schwannomas (VS)-Differences in Tumor Control, Symptoms and Quality of Life after Radiotherapy with Photon versus Proton Therapy.

Authors:  Maike Küchler; Rami A El Shafie; Sebastian Adeberg; Klaus Herfarth; Laila König; Kristin Lang; Juliane Hörner-Rieber; Peter Karl Plinkert; Wolfgang Wick; Felix Sahm; Simon David Sprengel; Jürgen Debus; Denise Bernhardt
Journal:  Cancers (Basel)       Date:  2022-04-10       Impact factor: 6.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.